Ilyda S.A.
ILYDA.AT
Athens Stock Exchange4.30
EUR
-0.04
- -
Ilyda S.A.
ILYDA.AT
(Athens Stock Exchange)
Recent
price
4.30
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Ilyda S.A. Ilyda SA is a Greece-based software development company that designs, develops, distributes, and supports enterprise resource planning (ERP) systems and specialized vertical market applications. Founded in 1992 and headquartered at Adrianeiou 29, Neo Psychiko, Athens, the company primarily serves the Greek market across industries including retail, pharmaceuticals, public utilities, education, financial institutions, and the public sector. Its core products and services encompass MegaTron ERP and Kinitron Smart ERP for general business resource management; Dioscourides Smart, Dioscourides Xpress, Dioscourides Touch, and Dioscourides ERP Retail System for pharmacies and point-of-sale programs in retail chains; MegaTron Pharma for pharmaceutical warehouse management; MegaTron DEYA for public water supply and sewerage enterprises; LIS Bio-Diagnosis for microbiological laboratories; PSIS Financial Management and PSIS Payroll & Personnel Management for public sector entities; SIS for educational institution secretariats; and custom-tailored software solutions, complemented by services such as project design and implementation, software support (telephone, remote, on-site, and feedback), user training, and consulting. Ilyda S.A. maintains partnerships as a certified Microsoft, Oracle, IBM, Dell, and Lenovo partner, enabling integrated IT solutions. Recent developments include the acquisition of 100% of Cardisoft S.A. from Entersoft S.A. in 2017 to bolster its software portfolio; earlier purchase of 55% of PROSVASIS A.E.B.E. in 2012 for specialized accounting software and publications; and establishment of subsidiary Dioscourides A.E. (with 65% ownership) and participation in Uni-Serv for pharmacy chain expansion, alongside entry into the Athens Stock Exchange main market and ongoing investment plans approved by the Ministry of Development for new product development and modernization exceeding €5 million. The company reported trailing twelve-month revenue of €8.81 million and net income of €4.27 million as of recent data, with approximately 48 employees focused on innovative ERP and vertical solutions.